Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics - Wikidata - awgldk - TriplyDB

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics

http://www.wikidata.org/entity/Q33648189

about

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma Current vaccine trials in glioblastoma: a review Cellular immunotherapy for pediatric solid tumors Adoptive cell therapies for glioblastoma In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy.Cellular and vaccine therapeutic approaches for gliomas Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia.Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy Immunotherapy of brain cancers: the past, the present, and future directions.Molecular alterations in glioblastoma: potential targets for immunotherapy.Cytotoxic T-cells as imaging probes for detecting glioma.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Cellular-based immunotherapies for patients with glioblastoma multiforme.Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients.Glioma big potassium channel expression in human cancers and possible T cell epitopes for their immunotherapy.Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients.Dendritic cell vaccination.The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.Emerging immunotherapies for glioblastoma Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape Recent advances and future of immunotherapy for glioblastoma.Immunotherapeutic approaches for glioma Immune-checkpoint blockade and active immunotherapy for glioma.Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.Toward effective immunotherapy for the treatment of malignant brain tumors Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy Cellular immunotherapy for high-grade glioma.Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy.Genetically modified T cells to target glioblastoma.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.

P2860

Q24615166-3D6F69AD-B0FF-4DA0-90E6-868BE7F81377 Q26828965-9B740769-D391-4CD5-B855-09D721CED31A Q27014912-3697F13A-4B14-437A-917C-8286617B7B12 Q27030863-8791A49F-5259-4933-AC96-544005C4E055 Q28389458-8EC0B036-AC0D-4D8A-AF15-13A3CBD6E92B Q33740546-89967C6E-71DE-4843-BF22-EFE4F73340A4 Q33779140-36B55CF7-FCB4-4B81-B588-0F9E8390D162 Q33999299-A0A32717-01A4-4112-904A-00F346C6B7A1 Q34102273-5BEDD2D3-04CF-4440-9E50-C59DC8E00A38 Q34140756-17F9C6D3-0133-4C74-8A36-FEC48AB3AA55 Q34177641-7C9FEB79-01C1-492A-8D36-1340DAEBDBBB Q34243550-30783024-46A0-4036-A6E5-D0C2EFCC4B36 Q34407938-693C7F23-431A-48C4-B601-9EFCC31823C0 Q34594769-AC464DED-9AE0-40D5-91DC-AFAE9B23B1E1 Q34701587-D6DC3ADB-E7F4-4D8F-B7FC-8C9403BEF7A4 Q34870511-3407B13D-0C92-4C96-9F3D-7FAB65CD6634 Q34983788-39F88F3A-0AC0-40A1-A25F-46D98066107A Q35799695-4C91D154-7D6F-4774-82C8-6F3A52A1BA6A Q35821404-4C0DA827-8103-479E-B2AE-184AC36AB8DA Q35878535-33045C57-8141-4872-A0FC-D6D655C3CFFA Q35955393-9BC3A6E8-FEFC-406D-AE65-F7CDA3CBDC02 Q36393422-9484184B-3928-47CC-A5E7-14B2C1907D88 Q36523499-7362F909-DA98-4470-96B6-BA25DA92D66A Q36597942-4EAEE295-F76C-48FB-8AD3-976D695DA21F Q36899104-308D5198-144B-438C-B392-29A9B895C21B Q36950556-8E168D6E-D398-4A2E-9119-BF5AD9085CD5 Q37025105-BAB0BEE9-774E-43F8-BCC9-CF694F6C2AF8 Q37137932-D21D6578-EFDC-4BAA-81FC-AB8ABCA6F917 Q37239071-7810474F-7646-4513-8448-9D53BA4CDB1F Q37267793-EB3A759F-95A9-47A9-A31A-64C72AAF784D Q37420586-4AC37D80-2F0F-4AA7-BE28-D6E138CD855E Q37435455-99B271F0-856C-40EA-8929-E43563B7BEA9 Q37533657-AF3AB8D9-FEF5-441B-952D-CD6CD6EB6FD8 Q37580419-D48CA1E6-95B7-4F95-B4FB-3DA04111AF4E Q37608106-DEC5824C-1918-48A8-A345-39C227B8E8CA Q37734481-8A8AA740-788B-4BE4-9567-1E6D2DDEC5B5 Q37851972-7A5F4F82-0C2C-4412-BD4B-6E343FB2975D Q37965751-D1B72357-1C9A-4317-8BAB-81EADFBA7148 Q38178690-0258FE61-C3AE-48B9-A532-7985691F55A6 Q38227889-379F7B81-84B1-4702-8952-5DC9668EE748

P2860

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics

http://www.wikidata.org/entity/Q33648189

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Antigenic profiling of glioma ...... dritic cell-based therapeutics

@ast

Antigenic profiling of glioma ...... dritic cell-based therapeutics

@en

type

label

Antigenic profiling of glioma ...... dritic cell-based therapeutics

@ast

Antigenic profiling of glioma ...... dritic cell-based therapeutics

@en

prefLabel

Antigenic profiling of glioma ...... dritic cell-based therapeutics

@ast

Antigenic profiling of glioma ...... dritic cell-based therapeutics

@en

P1433

Q33648189-2877FEC2-6F7A-4CBA-BFBD-7B50F1D4420E

P1476

Q33648189-EE56D40C-FBDB-491B-BDA7-76C49282629C

P2093

Q33648189-0CDC02C4-2F0B-4BF1-906A-CB2023781548

Q33648189-1326759B-9156-49F9-BAB0-08256469D9D0

Q33648189-23699309-AEB2-4B6C-BC71-289C226B3DE6

Q33648189-3AAEF56A-7770-4725-A545-EDA1B5F00BD0

Q33648189-3E045CE8-F1EC-40F0-BCB6-E14E65D05D55

Q33648189-59D9E425-84B7-4687-AB75-A5F930971473

Q33648189-6203AB31-893D-4819-97B8-1ADFA6FF4E80

Q33648189-A89C9D5A-0212-419D-B379-BD4F2C590F19

Q33648189-AF542B14-A5C9-4E2F-A522-F4F22F7DC587

Q33648189-B9BB10EB-F198-4208-84EF-E8824B841BA9

P2860

Q33648189-054C2157-9829-42D5-9355-2D0AB8C7604F

Q33648189-0C376FE0-5B61-4BA5-8531-9670A59DE943

Q33648189-1DB74B8C-60F3-4FD9-BBBF-B8772EF0AB9D

Q33648189-1DBFA221-FF44-43E1-B5E9-871BF55A62B0

Q33648189-1F8140CD-5D5C-4874-8E76-1F17F818C7AB

Q33648189-2A71EB4E-9FED-43FA-AC00-AA1899672B1E

Q33648189-2AF824E9-A977-4374-A5A6-DBE663F83D19

Q33648189-2FD575B5-2F10-4BC1-893A-78203BC01E24

Q33648189-3271EC48-2AE5-4CD2-A668-397C6DFE10CA

Q33648189-3F996AB3-8FA0-4DDF-9FC7-011194DAD7AD

P304

Q33648189-BDB53CE0-330C-42AA-967E-46BC1502432A

P31

Q33648189-06C84B4A-64E2-4C0B-A194-492625423BCE

P356

Q33648189-C17F5CFC-66AB-4983-9C88-2E36777CF050

P407

Q33648189-374CDB83-A5BE-479B-914C-A07B4F57FE5E

P433

Q33648189-907803B1-4622-46F1-974A-8DEE4889F8D9

P478

Q33648189-1D7847B2-18F5-45BB-8E54-01EE869D03F8

P577

Q33648189-FB8FED1D-82DC-4ABB-87CD-B84170E6BE06

P698

Q33648189-0DB6ABC1-A3F1-47BE-9F54-45DA3DD5FB24

P932

Q33648189-9EFF4D5F-C710-43B4-98A9-8F1CDCA14B6A

P356

1078-0432.CCR-06-1576

P1433

Clinical Cancer Research

P1476

Antigenic profiling of glioma ...... dritic cell-based therapeutics

@en

P2093

Boris Minev

http://www.w3.org/2001/XMLSchema#string

Carol A Kruse

http://www.w3.org/2001/XMLSchema#string

Christina Delgado

http://www.w3.org/2001/XMLSchema#string

German G Gomez

http://www.w3.org/2001/XMLSchema#string

H Terry Wepsic

http://www.w3.org/2001/XMLSchema#string

Habib Fakhrai

http://www.w3.org/2001/XMLSchema#string

Hideho Okada

http://www.w3.org/2001/XMLSchema#string

Jian Gang Zhang

http://www.w3.org/2001/XMLSchema#string

Junichi Eguchi

http://www.w3.org/2001/XMLSchema#string

Martin R Jadus

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

A new mathematical model for relative quantification in real-time RT-PCR

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain

Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor types.

Identification of a human glioma antigen, SOX6, recognized by patients' sera.

Glioma immunology and immunotherapy.

A listing of human tumor antigens recognized by T cells.

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells.

Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.

P304

566-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-06-1576

http://www.w3.org/2001/XMLSchema#string

P407

P433

2 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17255279

http://www.w3.org/2001/XMLSchema#string

P932

4030524

http://www.w3.org/2001/XMLSchema#string